Find Academic Supervisors

Rakesh MukherjeeView profile

Research Fellow

• Molecular Biology
• Biochemistry
• DNA Nanotechnology
• +2 more

Rakesh Mukherjee is a postdoctoral research associate at the Principles of Biomolecular Systems group, Imperial College London . His research focuses on autonomous, enzyme-free molecular templating systems using DNA strands to enable sequence-specific catalytic assembly with minimal product inhibition. Imperial College London (Current: Postdoctoral Research Associate) EPFL (Postdoc: Cyclic Peptide Inhibitors) Ben-Gurion University (PhD: Peptide Replication Networks) Indian Institute of Technology Guwahati (MSc: Organic Chemistry) Research Interests span DNA nanotechnology , molecular replication , and non-covalent/covalent bond engineering . Key work demonstrates: DNA-based catalytic dimerization with weak product inhibition through toehold/handhold displacement Scaling to trimerization and covalent bond formation using copper-catalyzed click chemistry Information propagation in non-biological contexts via sequence-specific templating Applications include: Diagnostics and molecular biophysics through DNA strand displacement circuits Labelled oligomers for downstream tasks like selective binding and gel formation Combinatorial libraries of biologically functional molecules via DNA-templated synthesis

Haian ZhengView profile

Associate Professor

• Complex Drug Products (CDP)
• Biologics and Biosimilars
• Botanical Drug Products (BDP)
• +7 more

Haian Zheng, PhD is an Associate Professor in the Department of Pharmaceutical Sciences at Albany College of Pharmacy and Health Sciences (ACPHS). His academic roles include teaching courses such as Pharmaceutics I & II, Pharmaceutical and Analytical Techniques, and supervising thesis research. He holds a B.S. in Pharmacy from Shanghai Medical University, an M.S. in Chemistry from the University at Albany, and a Ph.D. in Pharmaceutical Science from the University of Connecticut. His research focuses on Complex Drug Products (CDP), including Biologics, Botanical Drug Products (BDP), and Endocannabinoid System (ECS) mechanisms. Key projects explore drug delivery systems, regulatory science, and cannabinoid interactions with the blood-brain barrier. His work bridges molecular characterization, formulation design, and clinical efficacy to improve patient outcomes. Dr. Zheng has contributed to textbooks like Martin’s Physical Pharmacy and Shargel and Yu’s Applied Biopharmaceutics . His publications span drug stability, microemulsion formulations, and cannabinoid receptor biology. He actively engages in conferences discussing drug abuse pharmacology and regulatory science education. His teaching emphasizes hands-on research experiences, including Advanced Pharmacy Practice Experiences (APPE) and global health initiatives. He integrates computational modeling and innovative teaching methods into curricula to enhance student learning in pharmaceutical sciences.

Michael MatherView profile

Academic

• Malaria parasite physiology
• Mitochondrial functions
• Drug target identification
• +4 more

Michael Mather, PhD, is a Research Associate Professor in the Department of Microbiology & Immunology at Drexel University College of Medicine. His work focuses on the physiology of malaria parasites, particularly mitochondrial functions and energy metabolism, with an emphasis on identifying novel drug targets and understanding resistance mechanisms. He collaborates with the Center for Molecular Parasitology under Prof. Akhil Vaidya. Education: PhD from the University of Illinois (1984). His research includes studies on mitochondrial proteomics, ELQ drug candidates (e.g., ELQ-300), and functional genomics of Plasmodium species. He investigates mechanisms underlying drug resistance to antimalarials like atovaquone and explores synergistic drug combinations. Key research areas include mitochondrial electron transport, heme biosynthesis, and TCA cycle pathways, with a focus on their roles in parasite survival. His lab uses techniques such as BioID proximity labeling and genetic ablation to study mitochondrial components. Collaborations include NIH, Medicines for Malaria Venture, and the Wellcome Trust Sanger Institute. Publications span over two decades, emphasizing mitochondrial drug targets, antimalarial drug development, and parasite metabolism. His work contributes to understanding minimalistic metabolic strategies of Plasmodium and developing affordable, long-acting treatments.

• Molecular Imaging
• Nuclear Medicine
• Multimodal Imaging
• +7 more

Univ.-Prof. Dr. med. Michael Andreas Schäfers is a Full Professor of Nuclear Medicine and Director of the European Institute for Molecular Imaging (EIMI) and the Department of Nuclear Medicine at the University of Münster. He holds leadership roles, including Chairman of the German Universities Nuclear Medicine National Committee and membership in multiple medical societies. His expertise spans molecular imaging, translational research, and hybrid imaging techniques. Education includes a PhD from the University of Münster (1995) and habilitation (1999). Professional milestones include research at the MRC Cyclotron Unit (London, 1994–1995) and tenure-track professorship (1999–2007). His research focuses on multimodal molecular imaging, targeted imaging probes, cardiovascular inflammation, apoptosis, and hybrid imaging technologies. Key research interests include development of radiopharmaceuticals, PET/MRI integration, and imaging of inflammatory and oncological processes. Notable contributions include studies on FAP-directed radioligand therapy, S100A8/A9 alarmins, and glutamine's role in acute kidney injury. He has authored over 300 publications and holds patents on imaging agents. Scientific awards include recognition from Focus-Ärzteliste (2022), BurdaVerlag, and the Young Investigator Award (2004). He supervises the CiM-IMPRS Graduate Programme and contributes to clinical trials in oncology and radiopharmacology. His labs at EIMI and the Translational Imaging Group advance imaging technologies and preclinical/clinical collaborations.

Luisa TorriView profile

Professor

• Food Sensory Evaluation
• Consumer Science
• Chemosensory Perception
• +4 more

Luisa Torri is a Full Professor of Food Technologies at the University of Gastronomic Sciences (UNISG), Italy. She holds roles as Prorector, Director of the Sensory Analysis Lab, and Board Member of the PhD program in Ecogastronomy. Her work bridges food science, consumer behavior, and sustainability. Education: Master’s in Food Science (2002) and PhD in Food Biotechnology (2008) from the University of Milan. She joined UNISG in 2007 as Sensory Analysis Lab head, becoming Assistant Professor (2008), then Associate Professor (2018) before achieving Full Professor status in 2023. Research focuses on sensory evaluation, consumer psychology, and sustainable food systems. Key topics include novel food acceptance, chemosensory perception differences, and shelf-life analysis using electronic noses. She pioneered studies on jellyfish, cultivated meat, and circular economy applications in food. Teaches courses like Sensory Analysis, Sustainable Novel Foods, and Food Packaging. Leads interdisciplinary projects like SHEEP-UP (ovine biodiversity) and SusPlantIC4.5 (plant-based ice cream innovation). Collaborates with industry giants (Barilla, Ikea, Whirlpool) and publishes over 150 articles. Institutional roles include leadership in the Italian Society of Sensory Sciences and the Italian Scientific Food Packaging Group. Current research emphasizes consumer-driven sustainability transitions and digital gastronomy education.

Maria Bonaventura FORLEOView profile

Professor

• Agricultural Economics
• Environmental Economics
• Consumer Behavior Analysis
• +5 more

Prof. Maria Bonaventura FORLEO is a Full Professor of Economics at the University of Molise, Italy. Her research focuses on sustainability, consumer behavior, agricultural economics, and environmental policy. She has conducted extensive work on food systems, marine environmental protection, and eco-efficient supply chains. Her interdisciplinary studies bridge economics with environmental science, addressing topics like organic vs conventional food choices, seafood sustainability, and waste management innovations. Key areas of expertise include: Environmental economics and policy analysis Consumer decision-making in sustainable consumption Eco-labeling and market dynamics Food security and agri-food systems Marine plastic pollution mitigation Recent research trends reveal a focus on Gen Z's environmental awareness, blockchain applications in agri-food traceability, and the economic implications of diversified farming systems. Her studies often involve case studies from Italy and the Mediterranean region, emphasizing local economic development and rural sustainability. No scientific awards are explicitly mentioned in the provided texts. Her publications span over two decades (2008-2025), reflecting a consistent academic contribution to sustainability-related fields. Grant details and advising activities are not detailed in the current data.

Wajih Al-SoufiView profile

Professor

• Fluorescence Spectroscopy
• Supramolecular Dynamics
• Single Molecule Detection
• +3 more

Wajih Al-Soufi is a Professor of Physical Chemistry at the University of Santiago de Compostela (USC), Spain. Born in Hamburg, Germany, he earned his PhD in 1991 from the Georg-August University of Göttingen, focusing on tunneling effects in triplet hydrogen transfer. He joined USC in 1996 as an Assistant Professor, advancing to Full Professor in 2002. His research centers on fluorescence spectroscopy, supramolecular dynamics, and single-molecule detection, with applications in biomedicine and technology. He leads the Single Molecule Fluorescence research group and co-founded the XuvenCiencia Teaching Innovation Group, promoting science education through workshops and summer camps. Al-Soufi has supervised numerous PhD students and published extensively on topics like amyloid aggregation, molecular probes, and surfactant systems. His work bridges fundamental research with practical innovations, including optical sensors for anesthetic gases and educational kits for secondary schools. Education : Bachelor's in Physics (1987), Carolo-Wilhelmina University of Braunschweig and Georg-August University of Göttingen PhD (1991), Georg-August University of Göttingen (thesis: tunneling effects in triplet-state hydrogen transfer) Research Focus : Fluorescence spectroscopy, supramolecular systems, single-molecule analysis, amyloid dynamics, and biophysical chemistry. His lab develops techniques to study molecular interactions in real-time, with applications in Alzheimer’s research and biomaterials. Grants & Projects : Principal Investigator on projects like “Fluorescent Probes for Supramolecular Systems” (2007–2010) and “Amyloid Aggregation Studies” (2015–2017) Collaborations with institutions in Germany, Brazil, and Latin America Awards : National accreditation as Full Professor (2015), sustained recognition for research and teaching innovation. Labs/Teams : Director of the Fluorescence of Single Molecules research unit at USC’s Department of Physical Chemistry.

Jaya TrivediView profile

Clinical Professor

• Neuromuscular Disorders
• Clinical Neurophysiology
• Amyotrophic Lateral Sclerosis (ALS)
• +3 more

Jaya Trivedi, M.D., is a Clinical Professor and Vice Chair for Ambulatory Operations and External Relations in the Department of Neurology at UT Southwestern Medical Center. She specializes in neuromuscular disorders, including amyotrophic lateral sclerosis (ALS), myasthenia gravis, muscular dystrophy, and skeletal muscle channelopathies. Her clinical interests focus on improving diagnostic and therapeutic approaches for neuromuscular diseases, particularly through multi-center clinical trials and biomarker research. Dr. Trivedi’s research emphasizes translational medicine, including her role as co-PI of an NIH-funded Wellstone Training Core grant to train future neuromuscular investigators. She is part of the FSHD Clinical Trial Research Network (FSHD CTRN), advancing studies on facioscapulohumeral muscular dystrophy. Her work has contributed to landmark trials on non-dystrophic myotonia and periodic paralysis, with notable publications on denture cream-induced neurological issues and natural history studies in neuromuscular disorders. Her teaching activities include directing the ACGME-accredited Neuromuscular Medicine Fellowship Program and organizing annual CME conferences like the Brain Summit. She mentors residents and fellows, many of whom pursue academic careers. Dr. Trivedi holds leadership roles in professional organizations, including the Texas Neurological Society, and has received prestigious teaching awards, such as the Trephined Cranium Award (twice). Her research spans clinical trials, pharmacological interventions (e.g., eculizumab for myasthenia gravis), and biomarker development for ALS. She also investigates rare diseases like late-onset Pompe disease and explores the impact of dietary factors on ALS progression. Her contributions bridge clinical practice, education, and research in neuromuscular medicine.

• Neurodegenerative Diseases
• Epigenetics
• Molecular Biology
• +6 more

Dr. Andrew Phipps is a Lecturer in Dementia Studies at the University of Tasmania’s Wicking Dementia Research and Education Centre. He holds a PhD from the University of Tasmania (2019) and has been engaged in postdoctoral research since 2021, transitioning to his current faculty role in 2024. His research focuses on molecular and epigenetic mechanisms underlying neurodegenerative diseases, particularly Alzheimer’s and motor neuron disease (MND). Dr. Phipps has secured over $2.3M in research grants, including major awards from FightMND and the Motor Neurone Disease Research Australia. He has supervised one completed Master’s student and currently guides two PhD candidates. His work emphasizes epigenetic alterations in aging and disease, using advanced techniques like next-generation sequencing and CRISPR/Cas genomic editing. Key research interests include axon degeneration in MND, gene-environment interactions in ALS, and epigenetic reprogramming in Alzheimer’s models. Collaborations span national and international institutions, including the University of Cambridge. Dr. Phipps is also active in community advocacy, serving on the MND Association of Tasmania board. His publications in journals like Neurobiology of Aging and Frontiers in Ageing Neuroscience reflect expertise in histone modifications, DNA methylation, and neurodegenerative mechanisms. Awards include prestigious scholarships from Alzheimer’s Australia and the Yulgilbar Foundation.

Vladimir A. PozdinView profile

Assistant Professor

• Wearable health monitoring
• In-situ sensing
• Flexible electronics
• +3 more

Vladimir A. Pozdin is an Assistant Professor in the Department of Mechanical and Materials Engineering at Florida International University (FIU). He holds a secondary appointment within the university and is actively involved in research and academic leadership. His work focuses on advanced materials and wearable technologies with applications in healthcare monitoring and biomedical engineering. Research Interests: Wearable health monitoring systems In-situ sensing for medical diagnostics Flexible electronics integration Microphysiological systems modeling Light-responsive materials for biomedical applications His research emphasizes developing innovative wearable devices for real-time health tracking, including systems like wireless functional near-infrared spectroscopy for cognitive monitoring and smart wound dressings. He also explores microphysiological systems to model biological barriers and study cellular responses under hypoxic conditions. His work intersects materials science, biomedical engineering, and clinical applications, with a focus on translating lab innovations into practical healthcare solutions. Publications Trends: Recent articles highlight advancements in wearable sensor design, light-controlled peptide ligands for protein purification, and microfluidic models for tissue engineering. These studies often bridge organic electronics, molecular engineering, and clinical diagnostics to address unmet needs in personalized medicine and regenerative therapies. Awards & Recognition: No scientific awards explicitly mentioned in the provided texts. Advising & Grants: Details on student advising and funded grants are not available in this dataset. However, his involvement with initiatives like the CELL-MET and PATHS-UP Engineering Research Centers (ERCs) suggests participation in collaborative, industry-linked projects. Labs & Teams: Affiliated with FIU’s CELL-MET ERC (Cellular Microphysiological Models for Engineering and Toxicology) and PATHS-UP ERC (Personalized Advanced Therapeutic and Health Solutions Using Microphysiological Systems), focusing on translating microphysiological research into clinical and industrial applications.

Sanna-Kaisa HerukkaView profile

Research Professor

• Biomarkers for neurodegenerative diseases
• Alzheimer's disease
• Mild cognitive impairment
• +2 more

Sanna-Kaisa Herukka, MD, PhD, is Research Director at the Institute of Clinical Medicine, School of Medicine, Faculty of Health Sciences, University of Eastern Finland. A neurologist and neuroscientist, she leads the Biomarkers for Neurological Disorders group and several multi-disciplinary research teams focusing on fluid biomarkers in Alzheimer’s disease and related dementias. Education MD, University of Eastern Finland, 2011 PhD (Neurosciences), University of Eastern Finland, 2009 MSc (Applied Biotechnology), University of Eastern Finland, 2008 Research Focus Herukka’s work centers on the discovery, analytical validation, and clinical implementation of cerebrospinal fluid and blood-based biomarkers for early detection and differential diagnosis of neurodegenerative diseases. She has particular expertise in Alzheimer’s disease, mild cognitive impairment, frontotemporal lobar degeneration, and idiopathic normal-pressure hydrocephalus. Her team integrates proteomics, metabolomics, neuroimaging, and machine-learning approaches to improve diagnostic accuracy and prognostic stratification. Scientific Output & Trends Across more than 220 peer-reviewed publications, her recent work (2018-2025) demonstrates a clear emphasis on synaptic proteins, phosphorylated tau species (especially p-tau217), neurofilament light chain, and multimodal biomarker panels. Collaborative multinational studies (e.g., Nature Medicine 2025, JAMA Neurology 2022) highlight reproducible biomarker signatures that predict cognitive decline and therapeutic response. Grants & Collaborations She has received continuous competitive funding from the Academy of Finland, EU Joint Programme – Neurodegenerative Disease Research (JPND), and industry partnerships. Current consortium grants support the TWINGEN cohort, FinnGen clinical recall studies, and the UEF Brain Research Unit 2.0 infrastructure. Labs & Teams Herukka directs the UEF Biomarker Laboratory within the Brain Research Unit, which provides ISO-accredited CSF and blood biomarker analyses for academic and clinical trials across Europe. She also co-chairs the Clinical Alzheimer Research group and the NPH & Early AD program, integrating neurosurgery, neurology, and radiology expertise.

• Soft Matter Physics
• Liquid Crystals
• Interfacial Phenomena
• +3 more

Dr. Elizabeth K. Mann is Professor at Kent State University, specializing in soft matter physics and interfacial phenomena. She completed her PhD at Université Pierre et Marie Curie (Paris VI) in 1992 and conducted postdoctoral research in France and Switzerland. Her work bridges macromolecular science, odontology, and environmental engineering. Research focuses on complex interfacial phenomena in molecularly thin films, with expertise in Brewster angle microscopy and optical characterization techniques. Investigates phase behavior, hydrodynamics, and pattern formation in polymer liquid crystal films and biomimetic systems. Applications include biosensing, optical devices, and functional materials. Recent publications demonstrate strong focus on liquid crystal applications in optics (microlenses, biosensors), interfacial tension measurements, protein-lipid interactions, and hydrogen bonding in complex fluids. Work integrates experimental techniques including surface light scattering spectroscopy, neutron reflectivity, and advanced microscopy. Based at the Advanced Materials and Liquid Crystal Institute. No information provided regarding students, awards, or research grants.

Julian LangerView profile

Researcher

• Mass Spectrometry
• Structural Biology
• Proteomics
• +3 more

Julian Langer is the Head of the Mass Spectrometry Research Group at the Max Planck Institute for Biophysics, leading a team focused on advancing mass spectrometry methodologies and their applications in structural, molecular, and neuro-biology. His lab develops cutting-edge workflows and collaborates with instrument vendors to address complex biological questions. Key affiliations include the Max Planck Institutes for Biophysics and Brain Research, and active participation in DFG’s SPP 2002 (Small Proteins in Prokaryotes) and the BMBF’s MOEL-SOEL program. Research interests revolve around membrane protein complexes, proteome dynamics, and mass spectrometry imaging. Notable contributions include direct sequencing of membrane proteins, hydrogen/deuterium exchange (HDX-MS) for membrane transporters, and cell-type-specific proteome profiling in vivo. Recent work explores synaptic plasticity mechanisms, cholesterol transport in Mycoplasma, and the structural basis of respiratory enzymes. Publications highlight advancements in ATPase mechanisms, MLKL protein interactions, and engineered cereblon for drug discovery. The group utilizes state-of-the-art equipment, including Bruker, Thermo, and Waters mass spectrometers coupled to nano-UPLC systems. Collaborations with industry and academic partners drive innovations in biomolecular analysis. Advising includes mentoring PhD students in proteomics, structural biology, and neurobiology. Grants and funding support interdisciplinary projects at the interface of biophysics and molecular medicine. The lab’s work bridges fundamental research with translational applications in health and disease.

Ian K. WebbView profile

Associate Professor

• Bioanalytical Chemistry
• Chemical Biology
• Mass Spectrometry
• +4 more

Ian K. Webb is an Associate Professor in the Department of Chemistry and Chemical Biology at Indiana University Indianapolis, leading the Webb Lab which develops advanced mass spectrometry tools for structural biology of dynamic and disordered proteins. His research leverages ion mobility and gas-phase ion/ion chemistry to overcome limitations of traditional biophysical techniques. Webb earned his B.S. from The College of William and Mary (2008) and Ph.D. from Purdue University (2012), followed by postdoctoral training at Pacific Northwest National Laboratory under Richard Smith. His primary research focuses on covalent footprinting, crosslinking, and electrostatic reaction methodologies using mass spectrometry to study protein folding, proteoforms, and protein-protein interactions. Key applications target human disease mechanisms and cellular function, particularly for intrinsically disordered proteins where conventional structural methods fail. The lab emphasizes the 'three S's' of mass spectrometry: sensitivity, speed, and selectivity. Recent publications reveal a strong trend toward gas-phase structural proteomics, with innovations in ion/ion reaction kinetics, mobility-based separation, and multi-length crosslinker applications. Work spans method development (e.g., duel electrospray systems) to biological applications like α-synuclein conformational analysis. Scientific recognition includes: NSF CAREER Award for gas-phase structural methodology development Webb mentors five active graduate students (Gurav, Renbarger, Black, Dollar, Cain) and a postdoc (Davis), with past advisees including MS graduate Sexton and multiple undergraduates. His research is supported by the NSF CAREER Award and NIH MIRA grant focused on proteoform-structure relationships in disordered systems. The Webb Lab operates as an interdisciplinary team combining chemical labeling, native/top-down proteomics, and computational modeling to resolve impacts of proteoforms on protein system structure-function relationships.

Ana AlonsoView profile

Professor

• Metabolomics
• Metabolic Flux Analysis
• Plant Metabolism
• +4 more

Ana Alonso is Professor and Interim Director of the BioDiscovery Institute at the University of North Texas, with joint appointment in the Department of Biological Sciences. She directs the BioAnalytical Facility and leads research addressing global challenges in food and energy security. Research focuses on: Mass spectrometry-based metabolomics and 13C-based metabolic flux analysis Improving seed and plant metabolism for biofuel and industrial applications Understanding plant-microbe interactions Metabolism of human fungal pathogens Current projects include USDA-funded research mapping pathways for industrially relevant fatty acids and NIH-funded studies on intracellular proliferation of fungal pathogens. Her lab develops analytical platforms for metabolic profiling in plants and pathogens. Laboratory members include postdoctoral researchers and graduate students working on metabolic engineering and plant biotechnology projects.